Orlistat
4 customer reviewsOrlistat is a capsule medicine for adults with obesity or overweight with weight-related health risks. It is used alongside a reduced-calorie, low-fat diet. It works in the gut by blocking lipases so less dietary fat is absorbed.
What is it?
Orlistat is a weight‑loss medicine in capsule form used for adults with obesity, or overweight adults with weight‑related health risks. It supports weight control by blocking digestive enzymes (lipases), so part of the fat you eat is not absorbed. The key benefit is a local action in the gut that reduces absorbed dietary fat when combined with a reduced‑calorie, low‑fat diet.
Composition
Each capsule contains orlistat as the active ingredient. The capsule shell and inactive excipients support oral administration and stable delivery of the medicine in capsule form.
How to use?
Take 1 capsule by mouth three times daily with meals (or within 1 hour after a meal). Use water. If you skip a meal, or the meal contains no fat, you can skip that dose.
Start with the first dose on a day you can stay near a bathroom. The first week is when people learn what too much fat feels like.
Dietary Recommendations with Orlistat
Aim for a reduced‑calorie diet with lower fat intake, and spread fat across meals. Many clinical programs target about 30% of calories from fat (or less), because higher‑fat meals are the strongest trigger for oily stools and urgency.
Healthy fats still count. Olive oil, nuts, and avocado can still provoke symptoms if the portion is large.
How does it work?
- Route: Oral, by swallowing the capsule whole with water.
- Dose: 120 mg per dose.
- Frequency: 3 times per day.
- Timing: Take during a meal or up to 1 hour after a meal that contains fat.
- Duration: Use as directed by a healthcare professional, typically alongside a reduced-calorie, low-fat diet.
- Missed meal: Do not take a dose if a meal is skipped or contains no fat.
Indications
Orlistat is an active substance used as a weight loss aid for obesity and weight management. It belongs to the class of lipase inhibitors, meaning it works inside the digestive tract rather than by suppressing appetite or “speeding up” metabolism. Because its action is mainly in the gut, it has minimal systemic absorption compared with many other weight‑loss medicines.
The core idea is simple: dietary fats need to be broken down before your body can absorb them. Orlistat interferes with that breakdown, so a portion of fat passes through and is eliminated. This is why the main side effects are also gastrointestinal.
Comparison
Orlistat sits in a different place from many modern weight‑loss medicines because it blocks fat absorption rather than changing appetite pathways.
| Option type | How it works | What to expect |
|---|---|---|
| Orlistat | Lipase inhibitor in the gut; reduces absorbed dietary fat | GI side effects are common; no appetite suppression; works best with low‑fat diet |
| GLP‑1 receptor agonists (semaglutide) | Appetite regulation and slower gastric emptying | Often larger average weight loss; nausea is common; usually prescription‑led follow‑up |
| Sympathomimetics (phentermine) | Appetite suppression via adrenergic pathways | Can raise heart rate/BP and worsen anxiety/insomnia; short‑term use in many protocols |
Other names you may encounter in the medical literature include Qsymia (a combination approach), and older agents such as sibutramine (Reductil), which is no longer widely used in many markets because of cardiovascular risk concerns. “Weight loss supplements” vary widely in evidence and safety, and they do not share Orlistat’s clearly defined enzyme target.
Contraindications
- Pregnancy
- Breast-feeding
- Chronic malabsorption syndrome
- Cholestasis
- Known hypersensitivity to Orlistat
- Under 12 years of age
- Hyperoxaluria
- History of nephrolithiasis (kidney stones)
Not recommended for
Orlistat is designed for adults who need medical weight management and are prepared to pair it with diet changes. Many clinicians use BMI and comorbidity risk (hypertension, dyslipidaemia, prediabetes or type 2 diabetes, sleep apnoea) to decide if the benefit outweighs the nuisance side effects.
Side effects
Most side effects are gastrointestinal and correlate with how much fat is in the meal. People describe oily stools, flatulence with discharge, fecal urgency, loose stools, and increased bowel movements. These effects can be socially inconvenient, yet they also act as feedback that dietary fat is higher than planned.
A pattern I see a lot: symptoms are worst in week 1–2, then settle once the diet becomes consistent. When symptoms stay intense, the diet usually contains hidden fat (dressings, pastries, “keto snacks,” fried add‑ons) or the capsules are taken with large, high‑fat meals.
Common management strategies:
- Keep meal fat moderate and predictable.
- Separate a multivitamin from Orlistat timing.
- Hydrate well if stools become loose.
- Consider soluble fibre in the diet if loose stools persist.
Serious or rare events can occur, including allergic reactions, severe abdominal pain, hepatitis signals (dark urine, jaundice), and kidney stone risk related to increased urinary oxalate in susceptible people. The EMA and WHO pharmacovigilance frameworks treat these as uncommon and worth recognising early [4].
Common mistakes
These are the patterns that most often lead to disappointment or avoidable side effects.
- Taking it with very high‑fat meals and assuming the capsule will “cancel out” the meal. It won’t; it will usually cancel your plans for the next few hours.
- Using it for snacks and forgetting the main meals, which flips the benefit‑to‑side‑effect ratio.
- Skipping the multivitamin for months, then wondering why fatigue, dry skin, or easy bruising shows up. Fat‑soluble vitamins matter.
- Starting right before travel, weddings, or long meetings. The first week is a learning phase; pick a calmer week.
- Assuming it works for every diet style. Very high‑fat patterns tend to be poorly tolerated.
Doctor opinions
Doctors who prescribe Orlistat tend to position it as a tool for people who struggle most with high‑fat eating patterns. It is less appealing for someone whose main driver is sugary drinks, frequent grazing, or portion size without much fat, since Orlistat does not block sugar absorption and does not reduce hunger directly.
Clinicians also value that Orlistat’s action is local to the gut, which can be a comfort point for patients who are wary of centrally acting medicines. The GI effects are common, and many patients stop early because they were not prepared for the day‑to‑day practicalities. MOHAP‑aligned obesity care increasingly treats follow‑up and behaviour change support as part of the medication’s success, not an optional add‑on.
One more clinical nuance: if a patient reports “no GI effects at all” while eating normally, it can hint that doses are being missed or that meal fat is already very low.
Frequently asked questions
Orlistat starts working with the first dose because it blocks lipase enzymes in the gut during digestion. People often notice GI effects within 24–48 hours if meal fat is high, and that is also a signal the medicine is active. Visible weight change takes longer and depends on a sustained calorie deficit. EMA public assessment documents describe Orlistat’s mechanism as local and meal‑dependent, which is why timing with meals matters.
With very low‑fat meals, there is little dietary fat to block, so the added benefit from Orlistat becomes smaller. Many people still lose weight on a low‑fat, reduced‑calorie diet, but Orlistat contributes less when there is minimal fat to “intercept.” A balanced approach is usually easier to maintain than extreme fat restriction. WHO obesity management resources keep lifestyle measures as the foundation, with medicines as add‑ons when risk is higher.
Those effects happen because unabsorbed fat stays in the intestine and changes stool consistency. Higher‑fat meals produce more unabsorbed fat, so symptoms intensify. Many people find the pattern predictable after the first week: a creamy sauce or fried meal leads to symptoms later the same day. A Cochrane review of Orlistat trials describes GI events as the most frequent reason for discontinuation.
Because Orlistat can reduce absorption of vitamins A, D, E, and K, many clinicians advise taking a multivitamin at a separate time, often at bedtime. Separation reduces the chance that the vitamin is “caught” in the same fat‑blocking window. This is a long‑term practical point, not just a short course issue. EMA product information for Orlistat includes the fat‑soluble vitamin absorption warning as a key counselling topic.
If you missed the dose and the meal is already long finished, skip it and take the next capsule with the next meal. Doubling up later does not improve fat blocking, because the medicine needs to be present in the gut when the fat arrives. Many users find linking it to the first bite of a meal is the easiest memory cue. This timing logic matches how lipase inhibition is described in regulatory pharmacology summaries.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Orlistat — Comparison with alternatives
Orlistat Current
Alli
Ayurslim Best price Best rated
Hoodia
Xenical
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2009). Xenical (orlistat) — Summary of Product Characteristics (SmPC). ↑
- Cochrane (2016). Orlistat for overweight and obesity. ↑
- U.S. Food and Drug Administration (FDA) (2012). Xenical (orlistat) — Prescribing Information. ↑
- World Health Organization (WHO) (2022). Obesity and overweight. ↑